MedTrace Logo

A Clinical Study of iEPC Intervent Subjects With Cerebral Hemorrhagic Stroke

NCT03726814 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2018-11-01

No results posted yet for this study

Summary

This is a single centre、single arm、open-label，to investigate the safety and efficacy of EPC transplantation in the brain

Conditions

  • Stroke, Ischemic

Interventions

BIOLOGICAL

EPC treatment group

Brain injection EPC

Sponsors & Collaborators

  • Allife Medical Science and Technology Co., Ltd.

    lead INDUSTRY

Study Design

Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-31
Primary Completion
2018-12-31
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03726814 on ClinicalTrials.gov